SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Agenus (AGEN)

AGEN RSS Feed
Add AGEN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 12/12/2017 6:06:15 PM - Followers: 78 - Board type: Free - Posts Today: 1

http://www.agenusbio.com/

http://finance.yahoo.com/q/ks?s=AGEN+Key+Statistics

Agenus Inc., a biotechnology company, develops and commercializes immunotherapies for cancer and infectious diseases. It markets Oncophage vaccine for the treatment of adjuvant renal cell carcinoma (kidney cancer). The company also has various product candidates under development, which include QS-21 Stimulon adjuvant, which is in Phase III clinical trials for the treatment of non-small cell lung cancer, melanoma, malaria, and singles, as well as in Phase II clinical trials for the treatment of Alzheimer's disease. In addition, the company's product candidates under development comprise Prophage, which is in Phase II clinical trials for the treatment of glioma (brain cancer) and pediatric neurological tumors; and HerpV, which is in Phase I clinical trials for the treatment of genital herpes. Further, it has various other undisclosed vaccines in Phase I and II studies. The company was formerly known as Antigenics Inc. and changed its name in January, 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.




SureTrader
Interactive Brokers Advertisement
AGEN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AGEN News: Statement of Changes in Beneficial Ownership (4) 12/04/2017 04:15:24 PM
AGEN News: Stock Review for Biotech's Investors -- Spark Therapeutics, Agenus, Coherus Biosciences, and Acorda Therapeutics 11/28/2017 06:50:00 AM
AGEN News: Current Report Filing (8-k) 11/15/2017 04:07:36 PM
AGEN News: Agenus Receives License Fee of $4 Million USD from Merck 11/15/2017 09:25:00 AM
AGEN News: Securities Registration Statement (simplified Form) (s-3) 11/09/2017 04:22:21 PM
PostSubject
#983   Ouch! gameboy47112 12/12/17 06:06:15 PM
#982   Thank you me33. Doktornolittle 12/10/17 11:05:53 PM
#981   Link to a SEC filling. http://insideri.com/1098972_000128812317000039_0001288123 me33 12/10/17 08:55:02 PM
#980   Where did this rumor come from? "He transferred Doktornolittle 12/10/17 08:46:58 PM
#979   Thanks gameboy47112 12/09/17 07:12:08 AM
#978   No, he did not. He transferred them to me33 12/08/17 10:58:05 PM
#977   Ok, I guess I need to ask someone gameboy47112 12/08/17 09:09:40 PM
#976   I would say it will run to $5-$10 me33 12/08/17 01:58:04 AM
#975   This will run to a minimum $5 and UNDAUNTED 12/07/17 08:36:44 PM
#974   Yeah, a bunch of them are mine lol doncamel 11/16/17 03:49:13 AM
#973   Couldn't agree more, lack of jump in share ConstitutionNow 11/16/17 12:06:12 AM
#972   LEXINGTON, Mass., Nov. 15, 2017 /PRNewswire/ -- Agenus H2R 11/15/17 01:49:55 PM
#971   This is ridiculous, a licensing deal with Merck, doncamel 11/15/17 09:37:31 AM
#970   Thanks doncamel, H2R 11/08/17 03:24:41 PM
#969   The only reasoning behind the separation, in my doncamel 11/07/17 10:45:40 PM
#968   A couple of points from the CC H2R 11/07/17 09:55:02 PM
#967   Conference call happening at 11am today! Big moves Ares_The_Investor 11/07/17 10:41:30 AM
#966   Me too.. up,up and away !!! Armed n Hammered 11/06/17 05:37:34 PM
#965   I'm thinking he has big plans for AgenTus. faxedreceipts 11/06/17 12:27:20 PM
#964   Good point about AgenTus. That is the faxedreceipts 11/06/17 12:20:27 PM
#963   What’s going on here? Not even a small doncamel 11/03/17 11:13:44 AM
#962   I think I've done decent as far as lakingsphan0427 11/01/17 03:48:23 AM
#961   Dang you're good! A much better stock picker H2R 10/31/17 06:14:17 PM
#960   And of course if you want to diversify lakingsphan0427 10/31/17 05:23:07 PM
#959   You seem to like the BP stocks so lakingsphan0427 10/31/17 04:19:24 PM
#958   Yep, still in AGEN; It's a minor position H2R 10/31/17 02:39:45 PM
#957   Thanks H2R! I might take position on KERX lakingsphan0427 10/31/17 02:14:59 PM
#956   FYI, H2R 10/30/17 10:16:23 PM
#955   Two nice size insider purchases by CEO last ConstitutionNow 10/30/17 07:33:06 PM
#954   Bought a few $4 nov 17 calls today ConstitutionNow 10/27/17 04:32:50 PM
#953   Agenus to Report Q3 2017 Financial Results on H2R 10/27/17 03:31:21 PM
#952   According to technicals (RSI, MACD, Stochastic...), AGEN share RamiroGaliza 10/27/17 06:13:22 AM
#951   To this day AGEN is prolly the most lakingsphan0427 10/26/17 02:26:49 PM
#950   No kidding. H2R 10/26/17 01:27:57 PM
#949   We should be over $5.00 by now not Moe money 02 10/26/17 01:22:18 PM
#948   What’s up with this it’s trading like otc Moe money 02 10/26/17 12:46:14 PM
#947   Positive Recommendation from CDC's Advisory Committee H2R 10/26/17 12:11:14 PM
#946   Press Release October 25th 2017 http://investor.agenusbio.com/press-releases/all Ares_The_Investor 10/26/17 04:55:03 AM
#945   Not a word. H2R 10/25/17 04:59:39 PM
#944   Heard anything from IR yet? lakingsphan0427 10/25/17 03:26:31 PM
#943   I had a broker contact me week before UNDAUNTED 10/25/17 02:33:41 PM
#942   Ah, thanks Bryce. Appreciate the info. H2R 10/24/17 09:03:53 PM
#941   There was one thing that happened yesterday that bryce7517 10/24/17 06:20:58 PM
#940   Sent the following email to AGEN's IR: H2R 10/24/17 05:49:16 PM
#939   What on earth? H2R 10/24/17 05:38:49 PM
#938   * * $AGEN Video Chart 10-24-17 * * ClayTrader 10/24/17 05:28:59 PM
#937   Be updated on the news watch this video! Ares_The_Investor 10/24/17 03:21:50 PM
#936   Only thing I can think of is a StockRacer87 10/24/17 01:19:02 PM
#935   Well the stock is getting beat up like lakingsphan0427 10/24/17 11:39:39 AM
#934   It seems People are waiting for earnings day Ares_The_Investor 10/24/17 05:12:57 AM
PostSubject